Approval · Notice of Compliance 299 · 2004
MULTIHANCE: Notice of Compliance 299
Issued March 31, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 299
- Date
- March 31, 2004
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Contrast enhancement agent for magnetic resonance imaging (mri)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MULTIHANCE | 02248302 | Marketed |
Medicinal ingredients
- GADOBENATE DIMEGLUMINE 529 MG per ML